Trainings and Resources
32 Results (showing 1 - 10)
The University of Pittsburgh School of Pharmacy's Program Evaluation and Research Unit (PERU) has created a pre-implementation survey to collect information prior to implementation for sites onboarding to Innovative Health Systems Initiative (IHSI) projects.
COVID-19 has hit tribal members hard, especially those with opioid use disorders. Learn how providers and their American Indian/Alaska Native patients are adapting by offering safe treatment, prevention, and recovery services by telehealth, phone, and in person—all while respecting tribes' unique needs and cultures.
This resource is intended to provide guidance on the issues that OTPs should consider as they navigate the COVID-19 crisis.
Like all professions, the addictions treatment field is faced with the challenges of employee substance use and abuse and their impact on retention of quality staff. Because the addictions field employees a disproportionate number of individuals – by recent estimates close to half of the treatment workforce – in recovery, the field faces particular retention challenges. This toolkit provides meaningful and practical guidance to the problem of substance misuse among addictions professionals.
Patients and providers of opioid agonist therapy face unique challenges related to the pandemic. In emergency situations, Opioid Treatment Programs (OTPs) receive guidance from state and federal entities and must apply this guidance in their day-to-day operations.
Medications for opioid use disorder, including buprenorphine hydrochloride and methadone hydrochloride, are highly effective at improving outcomes for individuals with the disorder. For pregnant women, use of these medications also improves pregnancy outcomes, including the risk of preterm birth. Despite the known benefits of medications for opioid use disorder, many pregnant and nonpregnant women with the disorder are not receiving them.
The Increased Access to Medications for Opioid Use Disorder during the COVID-19 Epidemic and Beyond Webinar took placed on July 23, 2020 at 2pm. The presentation and other resources from the webinar are included.
While these efforts to mitigate the spread of COVID-19 affect everyone, patients treated with buprenorphine/naloxone for an opioid use disorder (OUD) will feel these disruptions more acutely, especially in rural communities.
This Guide on Prevention of Drug Use and Treatment of Drug Use Disorder in Rural Settings was prepared by the United Nations Office on Drugs and Crime Drug Prevention and Health Branch, in the context of the global project Treatnet II: OFID-UNODC Programme to prevent HIV/AIDS through Treatnet Phase II, with the aim of providing an awareness-raising tool and guidance for policymakers, public health officials, local authorities and other stakeholders in dealing with substance use issues in rural settings in their respective countries.
This report provides recommendations for actions that state and local leaders can take immediately to increase evidence-based practices, decrease arbitrary determinations, and prevent overdose deaths. The report also provides concrete steps that will, in the longterm, help dismantle a siloed system of unequal access and disparities and move towards an integrated system that promotes restorative justice, where people and families are treated with dignity, and where addiction is treated as a health and wellness matter rather than one of moral failing or criminality.